MedTrace Logo

Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI

NCT02462460 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2025-07-17

No results posted yet for this study

Summary

The purpose of this study is to create a rapid scan of the pancreas and ovaries that could be used in the future to screen patients at risk for pancreatic or ovarian cancers. Currently, Magnetic Resonance Imaging (MRI) examinations of the pancreas and ovaries can last 30-45 minutes each. The investigators hope to create a rapid pancreatic and ovarian MRI evaluation that can be used as a screening tool that is completed in approximately 15 minutes. They will compare different tools available on modern MRI scanners to see which one reliably offers high quality images of the pancreas and ovaries.

Conditions

  • Screening Breast MRI in Patients Who Are BRCA Mutation Carriers

Interventions

DEVICE

MRI

BEHAVIORAL

Optional Screening Questionnaire

Sponsors & Collaborators

Principal Investigators

  • Peter Sawan, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02462460 on ClinicalTrials.gov